+++
title = "Shkreli ordered to return $64M, is barred from drug industry"
description = "NEW YORK (AP) — Martin Shkreli must return $64.6 million in profits he and his former company reaped from jacking up the price and monopolizing the market for a lifesaving drug, a federal judge ruled Friday while also barring the provocative, imprisoned ex-CEO  from the pharmaceutical industry for the rest of his life."
date = "2022-01-15 00:10:15"
slug = "61e20ec922339ac0b5dd0dc6"
image = "https://storage.googleapis.com/afs-prod/media/4419be6a7af7468999aa22713b62ac61/3000.jpeg"
categories = ['return', 'company', 'ordered']
+++

NEW YORK (AP) — Martin Shkreli must return $64.6 million in profits he and his former company reaped from jacking up the price and monopolizing the market for a lifesaving drug, a federal judge ruled Friday while also barring the provocative, imprisoned ex-CEO  from the pharmaceutical industry for the rest of his life.

## Summary

- FILE - Former Turing Pharmaceuticals CEO Martin Shkreli attends the House Committee on Oversight and Reform Committee hearing on Capitol Hill in Washington, Feb. 4, 2016.
- A federal judge on Friday, Jan. 14, 2022 ordered Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.
- A federal judge on Friday, Jan. 14, 2022 ordered Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.
- Former Vyera CEO Kevin Mulleady agreed to pay $250,000 if he violates the settlement, which barred him from working for a pharmaceutical company” for seven years.
- The trial record included evidence showing Shkreli kept in regular contact with company executives, even after he went to prison.

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://apnews.com/article/martin-shkreli-daraprim-profits-fb77aee9ed155f9a74204cfb13fc1130">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
